Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: rustyjack who wrote (2031)	2/5/1998 6:33:00 PM
From: rl	Read Replies (3) \| Respond to of 3369

Ron, You should ask Mr. Slowey if SALV is making any money on the SeroStrip approval in India. That's what counts, not approval for approvals sake. Announcements of licensure in Romania and Kenya mean very little. The most interesting facet of the release today was about assembling in the UK as a second site. Where is the first? Why is the UK less expensive than Singapore? Most of the sales of SALV are in Asia, so what is so great about the UK? How will the UK/Wesley Coe site lead to "increasing the capacity we had prior to the cost-cutting measures of closing our Singapore plant in October." This sentence makes no sense. Is SALV saying that they will have more capacity than ever before, or that they are just getting back to where they were when they shut the Singapore facility down? It is not cheaper in the UK than Singapore, so what is the benefit? All of this ignores the pressing issue of the reverse split. I cannot vote for it. Reverse splits, more often than not, are a last gasp and do not have the result hoped for, except in the very short term. It is a bright red flag for brokers. The scenario appears to me to be that, if the split passes, the stock will be worth about $2.50, but only briefly. Then it will begin to decline. SALV will sell more stock in private placements at discounts. When that stock hits the market, as it surely will, the stock will decline. We'll be in the same price range as now, but will have 10 times fewer shares. The management at SALV cannot afford to sabotage the company to the point that it goes out of business. They are personally liable. One of the BOD members is a partner in the law firm that represents SALV also. These things lead to quite a bit of exposure to the BOD and management. Awarding themselves 1 million and 1/4 million options when the company stock is at its lowest in history is the epitomy of arrogance and completely disregards the rights of the shareholders. rl

To: rustyjack who wrote (2031)	2/5/1998 8:22:00 PM
From: Harold	Read Replies (1) \| Respond to of 3369

Thank you, We ALL should let them know how we feel about the split. I voted against it. It would be better if somehow we can enter the THICK SKULL of SDS's President and make him aware that shareholders are NOT IDIOTS. If HE and his accountants would come out and show us what lays ahead (probably as nothing is for sure in life)as far as $$'s, people would buy the stock and it would go to $1.00 then NO NEED for a split. McLachlan has SCREWED UP, he is the President therefore the buck stops with him. He just has SCREWED up, today's release had good news, was well put together. But! the question I have is " Since when has this numb skull known about these good news?" I truly cannot believe that the stock would have tanked as much as it has, had these news come out sooner. NOW!!!!here comes the multi million $$$$$$$'s question. Does he want the stock to split? if yes !!! WHY ???????? If anyone on this BB has a suggestion, please post. By the way SDS also has a Board of Directors and Executive Officers. Maybe we need to let them know how we feel, maybe we should tell them how to treat shareholders.